Tech Rout Knocks NASDAQ While Dow Gains; Investors Eye Value Stocks

The market is overreacting to macro fears (inflation, regulation) while ignoring structural crypto adoption drivers like on-chain settlement volume growth. Unrelated health news exemplifies how media noise amplifies irrational sentiment during bear markets, creating mispriced entry points.

The TB vaccine from the 1920s showed promise in a trial for type 1 diabetes, reducing insulin use for patients with type 1 diabetes and another autoimmune condition.

1920s TB Vaccine Trial for Diabetes Revives 'Proven Tech' Narrative – Could It Boost Bitcoin?

Vaccine Trial Reshapes Risk Appetite: How 'Proven Technology' Narrative Could Trigger Capital Rotation into Bitcoin

Jordi Visser: Bitcoin Still in a Bear Market, 200-Week MA Is the Line to Watch

Standard Chartered Analyst Sees Ethereum Outperforming Bitcoin After Strategy BTC Sale

Bitcoin Hits 4-Month Low as Investors Rotate to AI Stocks

Bitcoin Dips 3.4% to $65,500 as Glassnode Flags Selective Altcoin Strength

Hyperliquid's HYPE Token Surpasses Solana as SOL Sinks to 2023 Lows

Bitcoin's Slide Is About AI and IPO Rotations, Not Michael Saylor's Sales

000660.KS

In a crypto market gripped by extreme fear (F&G 11) and a 5.2% market cap decline in 24 hours, the strength of SK Hynix and Micron signals that institutional capital is rotating into proven, cash-flow-generating equities while avoiding crypto. This divergence suggests that the 'risk-on' narrative is not uniform; traditional tech is seen as a safe haven within the current macro environment, further draining liquidity from crypto markets.

SK Hynix

Micron Technology

SK Hynix and Micron were reported to have joined the $1 trillion market cap club.